cancer immunotherapy
Expanding the limits of personalized medicine with high-performance computing
Sound like wishful thinking? The first steps towards this vision have been undertaken by a multi-institution research collaboration that includes Jonathan Ozik…
Stable MHC proteins for cancer immunotherapy: Innovation from Jacobs University facilitates novel treatment methods
A Jacobs University work group, led by Prof. Sebastian Springer, professor for Biochemistry and Cell Biology, has recently published two papers in the journal…
Bacteria engineered as Trojan horse for cancer immunotherapy
The emerging field of synthetic biology–designing new biological components and systems–is revolutionizing medicine. Through the genetic programming of…
A new molecular player involved in T cell activation
During T-cell activation, a molecular complex known as the microtubule-organizing center (MTOC) moves to a central location on the surface of the T-cell.
New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories
Cancer immunotherapy — efforts to better arm a patient's own immune system to attack tumors — has shown great potential for treating some cancers. Yet…
Funding of Collaborative Research Center developing nanomaterials for cancer immunotherapy extended
The German Research Foundation (DFG) has agreed to fund the Mainz-based Collaborative Research Center (CRC) 1066 “Nanodimensional Polymer Therapeutics for…